Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 77

Neuralink connects to GV to raise $205m

GV was among the participants in a series C round that boosted the neurological communication technology developer's total funding to more than $360m.

Aug 2, 2021

Isar Aerospace increases scope of series B

Porsche was among the investors that supplied $75m to take the satellite launch vehicle developer's latest round to over $165m.

Aug 2, 2021

Algolia inputs $150m at a $2.25bn valuation

Salesforce and Twilio backed the API platform developer in a series D round led by Lone Pine Capital, bringing its overall funding to $315m.

Aug 2, 2021

Investors decode 1Password’s $100m series B

The Slack Fund-backed password management technology developer has raised a series B round that valued it at $2bn post-money.

Aug 2, 2021

Investors get into Grover’s $100m series B round

The Assurant and Samsung-backed consumer device rental service has secured $29m in a series B extension provided by unnamed backers.

Aug 2, 2021

Bota Bio sails to series B funding

The biological ingredient technology developer, which counts BASF Venture Capital and Baidu Ventures as investors, raised more than $100m.

Aug 2, 2021

Deep Genomics jumps into $180m series C

University of Toronto-linked Deep Genomics has picked up $180m in its series C round led by SoftBank Vision Fund 2.

Jul 30, 2021

Rakuten Medical racks up $166m

Rakuten and SBI have returned to chip into the precision immunotherapy developer’s series D round, which was led by General Catalyst.

Jul 30, 2021

Figure fits $200m into series D round

Mitsubishi UFJ Financial Group-backed lending marketplace operator Figure has collected $200m in series D financing from investors including Blockchain.com.

Jul 30, 2021

Deep Genomics taps SoftBank in $180m round

SoftBank and Alexandria Real Estate Equities helped the Bloomberg-backed genetic medicine developer raise series C funding to further expand its pipeline of RNA therapies.

Jul 30, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here